The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 10.49%, which has investors questioning if this is right ...

Guidelines from the Advisory Committee on Immunization Practices help physicians decide what vaccines to recommend to patients and are also used for determining insurance coverage in the U.S. The ...

Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...

"Depending on the products, patients and consumers in China may be affected very much by the tariffs, because the production ...

Dr Rob Grundy has been appointed for a three-year term as the new northern co-chair of the US-Ireland R&D Partnership ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

The Ohio AG’s office claims that GSK and its predecessor company hit an internal study in 1982 that showed Zantac can break ...